湖北能特科技股份有限公司 第七届董事会第三十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖北能特科技股份有限公司（以下简称"公司"）第七届董事会第三十五次 会议采取通讯表决的方式于 2025 年 10 月 27 日上午召开。本次会议由公司董事 长陈烈权先生召集和主持，会议通知已于 2025 年 10 月 24 日以专人递送、传真、 电子邮件等方式送达全体董事、监事和高级管理人员。本次会议应参加会议的董 事九人（发出表决票九张），实际参加会议的董事九人（收回有效表决票九张）。 本次会议的召集、召开符合《中华人民共和国公司法》和《公司章程》的有关规 定。 二、董事会会议审议情况 （一）以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过《关于取消监 事会并修订〈公司章程〉及部分公司制度的议案》。 本议案尚需提交公司 2025 年第六次临时股东大会审议。 证券代码：002102 证券简称：能特科技 公告编号：2025-095 （四）在关联董事邓海雄先生、黄浩先生（4203****3419）、构旭荣女士回 避表决的情况 ...

Revenue and Profitability - The company's revenue for Q3 2025 was ¥1,900,717,382.76, a decrease of 37.82% compared to the same period last year[5]. - Net profit attributable to shareholders increased by 79.29% to ¥113,590,156.94, while the net profit after deducting non-recurring items rose by 166.85% to ¥156,104,987.42[5]. - The basic earnings per share increased by 86.31% to ¥0.0449, and the diluted earnings per share also rose by 86.31% to ¥0.0449[5]. - Net profit for the current period is ¥461,357,384.03, compared to ¥129,037,027.12 in the previous period, indicating a significant increase of approximately 257.5%[21]. - Earnings per share (EPS) for the current period is ¥0.1743, up from ¥0.0457 in the previous period, representing an increase of approximately 281.4%[22]. Assets and Liabilities - Total assets decreased by 17.81% to ¥6,785,795,309.55 compared to the end of the previous year[5]. - Total liabilities amount to ¥3,276,665,916.43, a decrease from ¥4,548,049,639.81 in the previous period, reflecting a reduction of approximately 28.0%[18]. - The company’s total assets amount to ¥6,785,795,309.55, down from ¥8,256,108,014.43 in the previous period, reflecting a decrease of approximately 17.8%[18]. - The company’s total equity attributable to shareholders decreased by 5.36% to ¥3,314,038,570.06 compared to the end of the previous year[5]. - Total equity attributable to shareholders of the parent company is ¥3,314,038,570.06, down from ¥3,501,717,164.26, indicating a decrease of about 5.4%[18]. Cash Flow - Cash flow from operating activities showed a slight decrease of 1.50% to ¥88,273,038.50 year-to-date[5]. - The company’s cash inflow from operating activities totaled ¥8,815,817,841.24, compared to ¥10,113,793,201.28 in the previous period, showing a decrease of about 12.8%[22]. - Cash outflow for investment activities totaled $70,045,630.13, an increase from $62,535,829.67 in the previous period, reflecting a growth of approximately 11.5%[23]. - Net cash flow from financing activities was -$462,799,183.40, worsening from -$344,563,734.18 year-over-year[23]. - Cash and cash equivalents at the end of the period decreased to $98,116,458.50 from $110,585,461.62, representing a decline of about 11.2%[23]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 47,848[12]. - The top 10 shareholders hold a combined 45.34% of the shares, with Hubei Jingjiang Industrial Investment Group Co., Ltd. holding 13.67%[12]. - The company repurchased a total of 34,236,100 shares, accounting for 1.38% of the total share capital of 2,475,626,790 shares[13][14]. - The company plans to repurchase shares with a total amount not less than 300 million yuan and not exceeding 500 million yuan, at a price not exceeding 4.70 yuan per share[14]. Investment Income - The company reported a significant increase in investment income by 741.48%, attributed to the improved performance of its associate company[9]. - The company reported an investment income of ¥557,228,160.36, significantly higher than ¥66,219,830.43 in the previous period, marking an increase of approximately 740.5%[21]. Other Financial Metrics - The company experienced a 68.35% increase in accounts receivable, primarily due to the growth in trade business[9]. - The company reported a loss of ¥48,757,755.93 from the disposal of a subsidiary, impacting non-recurring gains and losses[6]. - The company’s weighted average return on equity was 3.41%, an increase of 1.88% compared to the same period last year[5]. - Total operating revenue for the current period is ¥7,129,503,021.35, a decrease of approximately 23.2% from ¥9,288,099,165.00 in the previous period[20]. - Total operating costs for the current period amount to ¥7,155,245,947.12, down from ¥9,237,542,005.95, reflecting a reduction of about 22.5%[20]. Inventory and Borrowings - Total current assets decreased from 4,824,414,679.67 yuan to 3,230,412,591.69 yuan, a decline of approximately 33.05%[16]. - Inventory decreased significantly from 2,234,929,465.83 yuan to 1,417,163,243.34 yuan, a reduction of approximately 36.54%[17]. - Short-term borrowings increased from 804,873,851.31 yuan to 982,371,884.75 yuan, an increase of about 22.05%[17]. Audit Status - The third quarter financial report was not audited, indicating a potential area of concern for stakeholders[24].

Group 1 - The core point of the news is that Nengte Technology's stock price increased by 5.09% to 3.92 CNY per share, with a trading volume of 151 million CNY and a turnover rate of 1.80%, resulting in a total market capitalization of 9.704 billion CNY [1] - Nengte Technology, established on September 28, 2002, and listed on December 29, 2006, is primarily engaged in the research, production, and sales of pharmaceutical intermediates, as well as investments in the research, production, and sales of Vitamin E, e-commerce for plastic trade, rental operations of investment properties, and gold mining [1] - The company's main business revenue composition includes 91.39% from plastic raw materials, 8.39% from pharmaceutical intermediates, and 0.22% from rental property service fees [1] Group 2 - From the perspective of major fund holdings, one fund under GF Fund has a significant position in Nengte Technology, specifically the GF CSI 2000 ETF (560220), which held 100,400 shares in the second quarter, accounting for 0.59% of the fund's net value, ranking as the seventh-largest holding [2] - The GF CSI 2000 ETF (560220) was established on September 8, 2023, with a latest scale of 53.7022 million CNY, achieving a year-to-date return of 34.1% and a one-year return of 49.87%, ranking 563 out of 3857 in its category [2] - The fund manager, Xia Haoyang, has a cumulative tenure of 4 years and 150 days, with the fund's total asset scale at 7.708 billion CNY, achieving the best return of 81.07% and the worst return of -32.56% during his tenure [2]

Core Viewpoint - The company, Nengte Technology (002102.SZ), has successfully executed a share buyback program, demonstrating its commitment to enhancing shareholder value through strategic capital management [1] Summary by Categories Share Buyback Details - As of September 30, 2025, the company has repurchased a total of 34,236,100 shares [1] - The repurchased shares account for 1.38% of the company's total share capital, which is 2,475,626,790 shares [1] - The highest transaction price during the buyback was 4.39 yuan per share, while the lowest was 3.97 yuan per share [1] - The total amount spent on the buyback reached 139.9864 million yuan, excluding transaction fees [1] Compliance and Strategy - The progress of the share buyback aligns with the company's established buyback plan and complies with relevant laws and regulations [1]

证券代码：002102 证券简称：能特科技 公告编号：2025-093 湖北能特科技股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 湖北能特科技股份有限公司（以下简称"公司"）于 2025 年 7 月 2 日召开 了第七届董事会第三十三次会议、第七届监事会第二十六次会议，于 2025 年 7 月 18 日召开了 2025 年第五次临时股东大会，审议通过了《关于回购股份并注销 的议案》，同意公司使用自有资金及自筹资金以资金总额不低于人民币 30,000 万元（含），不超过人民币 50,000 万元（含），回购价格不超过人民币 4.70 元/ 股（含），通过深圳证券交易所交易系统以集中竞价交易方式回购部分公司股份， 实施期限为自公司股东大会审议通过回购方案之日起 12 个月内（即 2025 年 7 月 19 日至 2026 年 7 月 18 日），具体回购股份的数量以回购方案实施完毕时实 际回购的股份数量为准。本次回购股份将全部用于注销并相应减少注册资本。具 体内容详见公司于 2025 年 7 月 19 日披露的《回购报 ...

Company Overview - Nengte Technology Co., Ltd. is located in Jingzhou, Hubei Province, and was established on September 28, 2002. The company was listed on December 29, 2006. Its main business includes the research, production, and sales of pharmaceutical intermediates, investment in the research, production, and sales of Vitamin E, e-commerce for plastic trade, rental of investment properties, and gold mining [1]. Financial Performance - As of June 30, 2025, Nengte Technology reported a revenue of 5.229 billion yuan, a year-on-year decrease of 16.09%. However, the net profit attributable to shareholders increased significantly by 496.36% to 339 million yuan [2]. - The company has cumulatively distributed 152 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Stock Performance - On September 16, Nengte Technology's stock price decreased by 2.06%, trading at 4.27 yuan per share, with a total market capitalization of 10.571 billion yuan. The stock has increased by 62.98% year-to-date, but has seen a decline of 3.83% over the last five trading days [1]. - The stock's trading volume on September 16 was 149 million yuan, with a turnover rate of 1.58%. The net outflow of main funds was 25.917 million yuan, with significant selling pressure observed [1]. Shareholder Information - As of June 30, 2025, the number of shareholders for Nengte Technology was 42,100, a slight decrease of 0.06% from the previous period. The average number of circulating shares per person increased by 0.06% to 55,391 shares [2]. - Notably, Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3]. Business Segmentation - The company's revenue composition is primarily from plastic raw materials (91.39%), followed by pharmaceutical intermediates (8.39%), and rental income from properties (0.22%) [1]. - Nengte Technology is classified under the pharmaceutical and biological industry, specifically in chemical pharmaceuticals and raw materials [1].

Group 1 - The core viewpoint of the news is that Nengte Technology's stock has increased by 5.42%, reaching a price of 4.67 CNY per share, with a trading volume of 292 million CNY and a turnover rate of 2.98%, resulting in a total market capitalization of 11.561 billion CNY [1] - Nengte Technology, established on September 28, 2002, and listed on December 29, 2006, is primarily engaged in the research, production, and sales of pharmaceutical intermediates, as well as investments in the research, production, and sales of Vitamin E, e-commerce for plastic trade, rental operations of investment properties, and gold mining [1] - The company's main business revenue composition includes 91.39% from plastic raw materials, 8.39% from pharmaceutical intermediates, and 0.22% from rental property service fees [1] Group 2 - From the perspective of fund holdings, one fund under GF Fund has a significant position in Nengte Technology, with the GF CSI 2000 ETF (560220) holding 100,400 shares, accounting for 0.59% of the fund's net value, ranking as the seventh largest holding [2] - The GF CSI 2000 ETF (560220) was established on September 8, 2023, with a latest scale of 53.7022 million CNY, achieving a year-to-date return of 36.17%, ranking 1032 out of 4222 in its category, and a one-year return of 87.3%, ranking 681 out of 3800 [2] - The fund manager, Xia Haoyang, has a total asset scale of 7.708 billion CNY, with the best fund return during his tenure being 67.3% and the worst being -38.82% [2]

Group 1 - The core viewpoint of the news is that Nengte Technology's stock has seen a significant increase of 5.42%, reaching a price of 4.67 yuan per share, with a trading volume of 292 million yuan and a turnover rate of 2.98%, resulting in a total market capitalization of 11.561 billion yuan [1] - Nengte Technology, established on September 28, 2002, and listed on December 29, 2006, is primarily engaged in the research, production, and sales of pharmaceutical intermediates, as well as the development and sales of Vitamin E. The company also operates in plastic trade e-commerce, investment real estate leasing, and gold mining [1] - The revenue composition of Nengte Technology shows that plastic raw materials account for 91.39% of total revenue, pharmaceutical intermediates contribute 8.39%, and rental property services make up 0.22% [1] Group 2 - From the perspective of fund holdings, one fund under E Fund has a significant position in Nengte Technology. The E Fund CSI 2000 ETF (159532) held 83,700 shares in the second quarter, representing 0.46% of the fund's net value, making it the eighth largest holding [2] - The E Fund CSI 2000 ETF (159532) was established on September 13, 2023, with a latest scale of 58.0843 million yuan. It has achieved a return of 38.76% year-to-date, ranking 879 out of 4222 in its category, and a return of 90.69% over the past year, ranking 584 out of 3800 [2] - The fund manager, Li Xu, has been in charge for 2 years and 292 days, with a total asset scale of 7.796 billion yuan. During his tenure, the best fund return was 103.35%, while the worst was 9.8% [2]

证券日报网讯能特科技（002102）9月11日在互动平台回答投资者提问时表示，公司主业为精细化工领 域，已于2025年7月通过公开挂牌转让了主要资产为金矿采矿权的陕西省安康燊乾矿业有限公司的100% 股权，详情请查询过往相关公告。 ...

证券代码：002102 证券简称：能特科技 公告编号：2025-092 湖北能特科技股份有限公司 关于减少注册资本并修订《公司章程》 暨完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、基本情况概述 湖北能特科技股份有限公司（以下简称"公司"）于 2025 年 7 月 2 日召开第七 届董事会第三十三次会议和第七届监事会第二十六次会议，审议通过了《关于注销 公司回购股份暨减少注册资本并修订〈公司章程〉的议案》，同意公司注销通过回 购专用证券账户以集中竞价交易方式累计回购的 156,953,700 股，并相应减少公司注 册资本，修订《公司章程》。公司已于 2025 年 7 月 31 日办理完成了 156,953,700 股 回购股份的注销手续。公司总股本由 2,632,580,490 股变更为 2,475,626,790 股，注册 资本由 2,632,580,490 元变更为 2,475,626,790 元。具体内容详见公司分别于 2025 年 7 月 3 日披露的《关于注销公司回购股份暨减少注册资本并修订〈公司章程〉的公告》、 20 ...